Daniel Arumi Selected Research

Incontinence Pads

5/2011

Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Arumi Research Topics

Disease

9	Overactive Urinary Bladder (Overactive Bladder) 02/2019 - 05/2011
3	Urinary Incontinence 02/2019 - 02/2015
2	Constipation 02/2019 - 06/2015
1	Neoplasms (Cancer) 01/2022
1	Venous Thromboembolism 01/2022
1	Urge Urinary Incontinence (Urge Incontinence) 06/2015
1	Urinary Retention 02/2015
1	Urinary Tract Infections (Urinary Tract Infection) 05/2011
1	Infections 05/2011

Drug/Important Bio-Agent (IBA)

8	fesoterodine FDA Link 02/2019 - 05/2011
5	Muscarinic AntagonistsIBA 10/2017 - 05/2011
1	Factor Xa InhibitorsIBA 01/2022
1	edoxabanIBA 01/2022
1	RivaroxabanIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	apixabanIBA 01/2022
1	Tolterodine Tartrate (Detrol)FDA Link 10/2017
1	Pharmaceutical PreparationsIBA 10/2013

Therapy/Procedure

1	Polypharmacy 01/2017
1	Therapeutics 06/2015
1	Home Nursing (Nursing, Home) 05/2011
1	Incontinence Pads 05/2011